Michelle Pressly
Overview
Explore the profile of Michelle Pressly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Humerickhouse C, Pressly M, Lin Z, Guinn D, Samuels S, Fletcher E, et al.
CPT Pharmacometrics Syst Pharmacol
. 2024 Oct;
13(11):1953-1966.
PMID: 39460526
Breastfeeding is important in childhood development, and medications are often necessary for lactating individuals, yet information on the potential risk of infant drug exposure through human milk is limited. Establishing...
2.
Yang X, Grimstein M, Pressly M, Fletcher E, Shord S, Leong R
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140068
Background: The treatment of cancer during pregnancy remains challenging with knowledge gaps in drug dosage, safety, and efficacy due to the under-representation of this population in clinical trials. Our aim...
3.
Kim S, Cicali B, Pressly M, da Silva L, Wendl T, Vozmediano V, et al.
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242635
Levonorgestrel (LNG) is a progestin used in many contraceptive formulations, including subcutaneous implants. There is an unmet need for developing long-acting formulations for LNG. To develop long-acting formulations, release functions...
4.
Cicali B, da Silva L, Sarayani A, Lingineni K, Pressly M, Kim S, et al.
Clin Pharmacol Ther
. 2022 Jun;
112(4):909-916.
PMID: 35723889
Worldwide, 922 million women of reproductive age (or their partners) use some sort of contraception to prevent pregnancy. Oral combined hormonal contraceptives (CHCs) typically utilize a combination of a progestin...